Searched for
ANTI PSORIASIS DRUG
How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...- Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
- Sun Pharma announces details of psoriasis drug trialsTildrakizumab is a monoclonal antibody designed to control the pathogenic cells responsible for the inflammatory process of psoriasis with ...
- Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
- Nine new drugs under clinical stage: Dr Reddy'sAccording to a filing with US SEC, the drug maker said as of March 31, 2014, it had 20 active products in the proprietary products pipeline.
- Dr Reddy's s Laboratories may spend $400 million on R&D over 3-4 yearsDr Reddy's Labs may invest up to $400 million on R&D over 3-4 years in biologics and proprietary products where a wave of big growth is exp...
- Biocon rolls out its first biologic drug for the treatment of psoriasisCalled ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kir...
- Six new drugs in clinical development stage: Dr Reddy'sThe drug maker said as of March 31, 2013, DRL had 21 active products in the proprietary products pipeline, of which six are in clinical dev...
- Biocon seeking partners to develop, market psoriasis drugBiotechnology major Biocon today said it is looking for partners to develop and market its novel biologic drug Itolizumab
- Biocon to launch psoriasis drug novel biologic in JulyThe company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
- Biocon gets approval to market anti-psoriasis drug Itolizumab by DCGIThe company said the approval paved the way for the launch of the product, under the brand name Alzumab.
- Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...
- Heard on the Street: Fund stocks up Biocon on drug launch buzzA large fund house belonging to a business conglomerate has been accumulating biotechnology company Biocon over the past two weeks on drug ...
- 'Lupin can conduct anti-psoriasis clinical trials'Lupin has received approval from the Drugs Controller General (India) to conduct a combined phase-IIb/III clinical trial for its herbal ant...
- Lupin gets DCGI nod for anti-psoriasis clinical trialsLupin has received approval from the Drugs Controller General (India) to conduct a combined phase-IIb/III clinical trial for its herbal ant...
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
Load More
